Filter Your Search

Clinical Trial Search

Keyword

Principal Investigator

Condition/Disease

For Healthcare Professionals

At Henry Ford Health System we serve a triple mission of Clinical Care, Research and Education. It is this triple mission that drives how we care for our patients, how we interact with referring physicians, how we work to innovate healthcare and how we train future physicians.

Learn More

Clinical Trials Search Results

PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

Principal Investigator:Ahmad H Mattour, MD

Status: Accepting Participants

Contact Phone: (888) 734-5322

Contact Email: [email protected]

GBM 001: An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma

Principal Investigator:Tobias Walbert, MD

Status: Accepting Participants

Contact Phone: (313) 916-3731

Contact Email: [email protected]

RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

Principal Investigator:Anza B Memon, MD

Status: Accepting Participants

Contact Phone: 313-916-1482

Contact Email: [email protected]

MS200527-0018 A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Principal Investigator:Kathleen M Maksimowicz-Mckinnon, DO

Status: Accepting Participants

Contact Phone: (313) 916-9328

Contact Email: [email protected]

Page 1 of 34 | Results 1 - 10 of 337

Browse Locations by Type Search All Locations

Frequently Searched ServicesSearch All Services

Browse Services by A-Z

Connect with Us

Resources

Research & Education

Clinical Trial Search

For Healthcare Professionals

Clinical Trials Search Results

PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

GBM 001: An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma

RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

MS200527-0018 A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Browse Locations by Type Search All Locations

Frequently Searched ServicesSearch All Services

Browse Services by A-Z

Connect with Us

Resources

Research & Education

Clinical Trial Search

For Healthcare Professionals

Clinical Trials Search Results

PTC-299-HEM-001-LEU: Phase 1b Study of PTC299 in Relapsed/Refractory Acute Leukemias

GBM 001: An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination with REGN2810 in Subjects with Newly-Diagnosed Glioblastoma

RPC-1063-MS-001: A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod

MS200527-0018 A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study Examining the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Consent for Cookie Use